How can we optimize the use of methotrexate to treat pediatric patients with inflammatory skin diseases?
.
Source: Expert Opinion on Drug Metabolism and Toxicology - Category: Drugs & Pharmacology Authors: Kajetan Kie Å‚bowskiEstera BakinowskaAndrzej PawlikDepartment of Physiology, Pomeranian Medical University, Szczecin, Poland Source Type: research
More News: Drugs & Pharmacology | Methotrexate | Pediatrics | Physiology | Poland Health | Skin | Toxicology